IDEXX Laboratories, Inc.
IDXX
$528.68
-$5.24-0.98%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.61% | -1.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.61% | -1.33% | |||
| Cost of Revenue | -3.33% | 2.51% | |||
| Gross Profit | 9.82% | -3.69% | |||
| SG&A Expenses | 10.38% | 0.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.60% | 2.08% | |||
| Operating Income | 11.70% | -8.52% | |||
| Income Before Tax | 15.79% | -10.96% | |||
| Income Tax Expenses | 30.96% | -16.20% | |||
| Earnings from Continuing Operations | 12.19% | -9.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.19% | -9.62% | |||
| EBIT | 11.70% | -8.52% | |||
| EBITDA | 10.17% | -7.19% | |||
| EPS Basic | 12.55% | -9.40% | |||
| Normalized Basic EPS | 12.84% | -8.12% | |||
| EPS Diluted | 12.36% | -9.17% | |||
| Normalized Diluted EPS | 12.93% | -8.13% | |||
| Average Basic Shares Outstanding | -0.31% | -0.25% | |||
| Average Diluted Shares Outstanding | -0.40% | -0.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||